RETRACTED: MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1 (Retracted article. See vol. 11, 2023)

被引:31
|
作者
Xu, Guo-shu [1 ]
Li, Zi-wei [2 ]
Huang, Zhi-Ping [3 ]
Brunicard, F. Charles [2 ]
Jia, Fu [4 ]
Song, Chao [5 ]
Zou, Hai-jian [4 ]
Sun, Rui-fen [4 ]
机构
[1] Tongde Hosp Zhejiang Prov, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[2] Univ Toledo, Dept Surg, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
[3] Gen Hosp Guangzhou Mil Command PLA, Dept Hepatobiliary Surg, Guangzhou 510000, Guangdong, Peoples R China
[4] Yunnan Univ Chinese Tradit Med, Ctr Sci Res, Kunming, Yunnan, Peoples R China
[5] Kunming Med Univ, Natl Clin Key Specialty, Dept Orthoped, Yanan Hosp, Kunming, Yunnan, Peoples R China
来源
基金
美国国家卫生研究院;
关键词
biomarker; hepatocellular carcinoma; IGF1; miR-497-5p; proliferation; FACTOR-I; CANCER; MICRORNAS; MUSCLE; INVASION; IGF-1; AXIS;
D O I
10.1002/mgg3.860
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR-497-5p has been reported in various human malignancies. However, the role of miR-497-5p in hepatocellular carcinoma (HCC) remains unclear. Results In this study, we found that miR-497-5p was downregulated in HCC tissues. The low level of miR-497-5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor prognosis in HCC patients. The overexpression of miR-497-5p significantly inhibited HCC cell proliferation, colony formation, and metastasis in vitro and vivo. Bioinformatics analysis further identified insulin-like growth factor 1 (IGF1) as a novel target of miR-497-5p in HCC cells. Conclusion Our study suggested that miR-497-5p regulates HCC cell survival, partially through downregulation of IGF1. Therefore, the miR-497-5p/IGF1 axis might serve as a novel therapeutic target in patients with HCC.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] RETRACTED: miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN (Retracted article. See vol. 47, 2022)
    Liu, Kai
    Liu, Songyang
    Zhang, Wei
    Jia, Baoxing
    Tan, Ludong
    Jin, Zhe
    Liu, Yahui
    ONCOLOGY REPORTS, 2015, 34 (02) : 1003 - 1010
  • [32] RETRACTED: KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo (Retracted article. See vol. 26, pg. 345, 2023)
    Wang, Xing
    Wang, Meng
    Li, Xing-Yue
    Li, Jian
    Zhao, Dian-Peng
    ONCOLOGY LETTERS, 2019, 18 (06) : 5739 - 5746
  • [33] RETRACTED: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3 (Retracted article. See vol. 11, pg. 4166, 2021)
    Yang, Shiming
    Chen, Zhi
    Fan, Daguang
    Zhang, Rui
    Zhang, Yuhong
    Wu, Shusheng
    RSC ADVANCES, 2018, 8 (61) : 34973 - 34983
  • [34] RETRACTED: miR-497 inhibits tumor growth and migration of osteosarcoma by targeting plexinA4 and CDK6 (Retracted article. See vol. 69, 2022)
    Tian, Z. S.
    Yan, M. J.
    Li, S.
    Cong, D.
    Wang, Y. Y.
    Zhu, Q. S.
    NEOPLASMA, 2020, 67 (05) : 1122 - 1130
  • [35] RETRACTED: Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p (Retracted article. See vol. 294, 2022)
    Li, Changchun
    Wang, Shan
    Yang, Chao
    LIFE SCIENCES, 2020, 252
  • [36] RETRACTED: MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3 (Retracted article. See vol. 62, 2023)
    Qiu, Jing
    Zhang, Yongzhi
    Chen, Hu
    Guo, Zhi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (04) : 1493 - 1504
  • [37] RETRACTED: MicroRNA-548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein 1 (Retracted article. See vol. 24, 2022)
    Qiu, Haile
    Zhang, Gehong
    Song, Bin
    Jia, Junmei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 2332 - 2340
  • [38] RETRACTED: MicroRNA-708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1 (Retracted article. See vol. 27, 2023)
    He, Jun
    Xiang, Deng
    Lin, Yanshui
    MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 3948 - 3954
  • [39] RETRACTED: MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1 (Retracted article. See vol. 22, 2021)
    Zou, Quanqing
    Tang, Qianli
    Pan, Yinhua
    Wang, Xuedi
    Dong, Xiaofeng
    Liang, Zhongxiao
    Huang, Dong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1009 - 1016
  • [40] RETRACTED: MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1 (Retracted article. See vol. 24, pg. 7206, 2020)
    Wang, Y-P
    Liu, J.
    Liu, D.
    Wang, X-D
    Bian, A-M
    Fang, D-Z
    Hui, X-B
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (20) : 8964 - 8970